Get started
Author

Goonaseelan Colin Pillai

Observed names: G Pillai, Goonaseelan ( Colin) Pillai, Goonaseelan (Colin) Pillai, Goonaseelan (colin Pillai Phd, Goonaseelan C. Pillai, Goonaseelan Pillai, Goonaseelan ‘Colin’ Pillai, Pillai, Goonaseelan, Pillai, Goonaseelan (Colin)
Observed institutions: F. Hoffmann-La Roche AG, Novartis (Switzerland), University of Cape Town, Groote Schuur Hospital, Allgemeine Gewerbeschule Basel, Novartis Institutes for BioMedical Research
ORCID: 0000-0002-5658-3837
Observed ORCID: 0000-0002-5658-3837
OpenAlex ID: A5065075350
Pharmacokinetics/Pharmacodynamics of Bisphosphonates
2005 · Serge C L M Cremers, Goonaseelan (Colin) Pillai, et al. · Clinical Pharmacokinetics · 238
Pharmacokinetic Evaluation of the Penetration of Antituberculosis Agents in Rabbit Pulmonary Lesions
2011 · Maria C. Kjellsson, Laura E. Via, et al. · Antimicrobial Agents and Chemotherapy · 165
Population Pharmacokinetics of Rifampin in Pulmonary Tuberculosis Patients, Including a Semimechanistic Model To Describe Variable Absorption
2008 · Justin J. Wilkins, Radojka M. Savic, et al. · Antimicrobial Agents and Chemotherapy · 150
Variability in the population pharmacokinetics of isoniazid in South African tuberculosis patients
2011 · Justin J. Wilkins, Grant Langdon, et al. · British Journal of Clinical Pharmacology · 105
PDF
Non-Linear Mixed Effects Modeling – From Methodology and Software Development to Driving Implementation in Drug Development Science
2005 · Goonaseelan (Colin) Pillai, France Mentré, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 99
A semimechanistic and mechanistic population PK–PD model for biomarker response to ibandronate, a new bisphosphonate for the treatment of osteoporosis
2004 · Goonaseelan Pillai, Ronald Gieschke, et al. · British Journal of Clinical Pharmacology · 87
PDF
Variability in the population pharmacokinetics of pyrazinamide in South African tuberculosis patients
2006 · Justin J. Wilkins, Grant Langdon, et al. · European Journal of Clinical Pharmacology · 76
Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development
2012 · I Demin, B Hamrén, et al. · Clinical Pharmacology & Therapeutics · 55
The Next Generation Scientist program: capacity-building for future scientific leaders in low- and middle-income countries
2018 · Goonaseelan Pillai, Kelly Chibale, et al. · BMC Medical Education · 41
PDF
Needs‐driven talent and competency development for the next generation of regulatory scientists in Africa
2021 · Boitumelo Semete‐Makokotlela, Gugu N. Mahlangu, et al. · British Journal of Clinical Pharmacology · 33
PDF
Population pharmacodynamic model of the longitudinal FEV1 response to an inhaled long-acting anti-muscarinic in COPD patients
2010 · Kai Wu, Michael Looby, et al. · Journal of Pharmacokinetics and Pharmacodynamics · 33
Care-Seeking Dynamics among Patients with Diabetes Mellitus and Hypertension in Selected Rural Settings in Kenya
2019 · Miriam Karinja, Goonaseelan Pillai, et al. · International Journal of Environmental Research and Public Health · 28
PDF
Pharmacometrics: Opportunity for Reducing Disease Burden in the Developing World: The Case of Africa
2013 · G Pillai, G Davies, et al. · CPT Pharmacometrics & Systems Pharmacology · 27
PDF
Open-source mobile digital platform for clinical trial data collection in low-resource settings
2017 · Joris van Dam, Kevin Omondi Onyango, et al. · BMJ Innovations · 25
PDF
Traditional medicines for COVID‐19: Perspectives from clinical pharmacologists
2021 · Getnet Yimer, Edmund Ekuadzi, et al. · British Journal of Clinical Pharmacology · 23
PDF
Fostering drug discovery and development in Africa
2022 · Susan Winks, John G. Woodland, et al. · Nature Medicine · 22
Emerging Therapeutics, Technologies, and Drug Development Strategies to Address Patient Nonadherence and Improve Tuberculosis Treatment
2021 · Maria Garcia-Cremades, Belen P. Solans, et al. · The Annual Review of Pharmacology and Toxicology · 22
PDF
Risk reduction of diarrhea and respiratory infections following a community health education program - a facility-based case-control study in rural parts of Kenya
2020 · Miriam Karinja, Raymond Schlienger, et al. · BMC Public Health · 20
PDF
Pharmacokinetic Similarity of Biologics: Analysis Using Nonlinear Mixed-Effects Modeling
2011 · A Dubois, S Gsteiger, et al. · Clinical Pharmacology & Therapeutics · 20
Clinical Pharmacology Worldwide: A Global Health Perspective
2021 · Larissa Wenning, Goonaseelan (Colin) Pillai, et al. · Clinical Pharmacology & Therapeutics · 18
Population Pharmacokinetics of Valsartan in Pediatrics
2009 · Bahru Habtemariam, William Sallas, et al. · Drug Metabolism and Pharmacokinetics · 14
Building Capability for Clinical Pharmacology Research in Sub‐Saharan Africa
2017 · MM Gutierrez, G Pillai, et al. · Clinical Pharmacology & Therapeutics · 13
Advancing pharmacometrics in Africa—Transition from capacity development toward job creation
2024 · Goonaseelan (Colin) Pillai, Samer Mouksassi, et al. · CPT Pharmacometrics & Systems Pharmacology · 10
PDF
Dolutegravir pharmacokinetics during co-administration with either artemether/lumefantrine or artesunate/amodiaquine
2021 · Aida N Kawuma, Stephen I Walimbwa, et al. · Journal of Antimicrobial Chemotherapy · 10
Barriers to global pharmacometrics: educational challenges and opportunities across the globe
2023 · Robin Michelet, Linda B. S. Aulin, et al. · CPT Pharmacometrics & Systems Pharmacology · 9
PDF
Works count: 64
Citation count: 1,413
H-index: 19
I10-index: 24
Year
Topic
Type